Stay updated on First-Line Atezolizumab Combos in Head and Neck Clinical Trial

Sign up to get notified when there's something new on the First-Line Atezolizumab Combos in Head and Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the First-Line Atezolizumab Combos in Head and Neck Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a new build/version in the site's records. No user-visible content or study details are altered by this change.
    Difference
    0.0%
    Check dated 2026-05-15T05:57:36.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Adds the official study results posted on 2026-05-05, detailing the confirmed objective response rate and related efficacy endpoints (DOR, PFS, OS) with their definitions and timeframes. Concurrently, several older results metrics were removed or deprecated to reflect the updated results package.
    Difference
    2%
    Check dated 2026-05-08T09:50:02.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-24T06:27:07.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added: Results Submitted and Revision: v3.5.2; removed: No Results Posted and Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:55.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added Squamous cell carcinoma of the head and neck as a condition and included the Genetic and Rare Diseases Information Center as a related resource.
    Difference
    0.1%
    Check dated 2026-04-02T15:54:37.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. There are no changes to the study data, eligibility criteria, outcomes, or listed locations.
    Difference
    0.0%
    Check dated 2026-03-19T08:40:09.000Z thumbnail image

Stay in the know with updates to First-Line Atezolizumab Combos in Head and Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the First-Line Atezolizumab Combos in Head and Neck Clinical Trial page.